David Rescott
Stock Analyst at Truist Securities
(3.21)
# 1,099
Out of 5,036 analysts
70
Total ratings
49.12%
Success rate
2.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SIBN SI-BONE | Maintains: Buy | $22 → $20 | $15.34 | +30.38% | 7 | Oct 15, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $123 → $128 | $99.78 | +28.28% | 9 | Oct 1, 2025 | |
| MDT Medtronic | Maintains: Neutral | $94 → $96 | $95.95 | +0.06% | 7 | Aug 20, 2025 | |
| PEN Penumbra | Maintains: Buy | $300 → $310 | $247.57 | +25.22% | 31 | Jul 30, 2025 | |
| EW Edwards Lifesciences | Maintains: Neutral | $78 → $79 | $76.02 | +3.93% | 5 | Jul 25, 2025 | |
| HAE Haemonetics | Initiates: Outperform | $87 | $50.88 | +70.99% | 1 | Jun 26, 2025 | |
| LIVN LivaNova | Maintains: Outperform | $55 → $61 | $54.88 | +11.16% | 4 | May 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $111 → $110 | $83.77 | +31.31% | 3 | Apr 25, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $600 → $575 | $463.73 | +23.99% | 3 | Apr 23, 2025 |
SI-BONE
Oct 15, 2025
Maintains: Buy
Price Target: $22 → $20
Current: $15.34
Upside: +30.38%
Boston Scientific
Oct 1, 2025
Maintains: Outperform
Price Target: $123 → $128
Current: $99.78
Upside: +28.28%
Medtronic
Aug 20, 2025
Maintains: Neutral
Price Target: $94 → $96
Current: $95.95
Upside: +0.06%
Penumbra
Jul 30, 2025
Maintains: Buy
Price Target: $300 → $310
Current: $247.57
Upside: +25.22%
Edwards Lifesciences
Jul 25, 2025
Maintains: Neutral
Price Target: $78 → $79
Current: $76.02
Upside: +3.93%
Haemonetics
Jun 26, 2025
Initiates: Outperform
Price Target: $87
Current: $50.88
Upside: +70.99%
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55 → $61
Current: $54.88
Upside: +11.16%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111 → $110
Current: $83.77
Upside: +31.31%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600 → $575
Current: $463.73
Upside: +23.99%